PepGen Inc. Securities Fraud Class Action Lawsuit
On June 13, 2025,
Levi & Korsinsky, LLP made an important announcement for investors in
PepGen Inc. (NASDAQ: PEPG) regarding a class action securities lawsuit. This legal action has been initiated to seek redress for shareholders who may have suffered financial losses due to alleged fraudulent activities.
Class Definition and Allegations
The lawsuit aims to recover losses incurred by investors adversely affected by
alleged securities fraud occurring between
March 7, 2024, and
March 3, 2025. According to the filed complaint, defendants are accused of making misleading statements concerning the company’s lead product candidate,
PGN-EDO51. The lawsuit outlines several key allegations, notably that:
1. The
effectiveness and safety of PGN-EDO51 were overstated to investors.
2. The
CONNECT2 study, which is a crucial aspect for seeking approval from the U.S. Food and Drug Administration (FDA), was reportedly deficient or unsafe.
3. Consequently, this led to a likely halt in the study, which altered the perceived commercial viability and regulatory prospects of PGN-EDO51.
4. The investors were misled, with the public statements issued by the defendants being fundamentally false and misleading.
Next Steps for Investors
Affected investors who lost money during the specified period have until
August 8, 2025, to request the court to appoint them as lead plaintiffs. It's crucial to note that participating in the lawsuit does not necessitate serving as a lead plaintiff—investors can still seek compensation without such a role.
Financial Considerations
Any class member eligible for recovery may do so without any costs or obligations. Levi & Korsinsky emphasizes that participating in the lawsuit bears no financial burden upfront, ensuring that aggrieved shareholders can pursue their claims without incurring expenses.
Why Choose Levi & Korsinsky?
With an extensive track record spanning
20 years, Levi & Korsinsky has successfully recovered hundreds of millions of dollars for shareholders and is renowned for its proficiency in complicated securities litigation. The firm boasts a dedicated team of over
70 employees, positioning them to better serve their clients in navigating the complexities of these legal battles.
For seven consecutive years, Levi & Korsinsky has been recognized as a leading firm in securities litigation according to the
ISS Securities Class Action Services Top 50 Report.
How to Get More Information
Investors looking to learn more about this class action lawsuit can follow a dedicated link to receive further information and have a representative contact them. Investors can also reach out directly to
Joseph E. Levi, Esq. at the following:
- - Email: [email protected]
- - Phone: (212) 363-7500
Final Thoughts
As stakeholders in
PepGen Inc. navigate this challenging period, understanding their rights and the legal options available is crucial. This ongoing class action serves as a pivotal opportunity for investors to seek justice and potentially recover their losses related to the alleged misconduct.
For further details and updates on this case, stay tuned and ensure you know your rights. You can also visit
Levi & Korsinsky’s website for comprehensive information on how to proceed.